1. Home
  2. PT vs BIAF Comparison

PT vs BIAF Comparison

Compare PT & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PT
  • BIAF
  • Stock Information
  • Founded
  • PT 2012
  • BIAF 2014
  • Country
  • PT China
  • BIAF United States
  • Employees
  • PT N/A
  • BIAF N/A
  • Industry
  • PT Computer Software: Programming Data Processing
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • PT Technology
  • BIAF Health Care
  • Exchange
  • PT Nasdaq
  • BIAF Nasdaq
  • Market Cap
  • PT 15.2M
  • BIAF 12.2M
  • IPO Year
  • PT 2018
  • BIAF 2022
  • Fundamental
  • Price
  • PT $0.90
  • BIAF $0.30
  • Analyst Decision
  • PT
  • BIAF Hold
  • Analyst Count
  • PT 0
  • BIAF 1
  • Target Price
  • PT N/A
  • BIAF N/A
  • AVG Volume (30 Days)
  • PT 15.7K
  • BIAF 11.2M
  • Earning Date
  • PT 07-07-2025
  • BIAF 08-13-2025
  • Dividend Yield
  • PT N/A
  • BIAF N/A
  • EPS Growth
  • PT N/A
  • BIAF N/A
  • EPS
  • PT N/A
  • BIAF N/A
  • Revenue
  • PT $4,814,566.00
  • BIAF $8,809,228.00
  • Revenue This Year
  • PT N/A
  • BIAF N/A
  • Revenue Next Year
  • PT N/A
  • BIAF $20.00
  • P/E Ratio
  • PT N/A
  • BIAF N/A
  • Revenue Growth
  • PT N/A
  • BIAF 78.40
  • 52 Week Low
  • PT $0.76
  • BIAF $0.16
  • 52 Week High
  • PT $1.15
  • BIAF $2.99
  • Technical
  • Relative Strength Index (RSI)
  • PT 46.18
  • BIAF 50.96
  • Support Level
  • PT $0.82
  • BIAF $0.22
  • Resistance Level
  • PT $0.94
  • BIAF $0.46
  • Average True Range (ATR)
  • PT 0.06
  • BIAF 0.04
  • MACD
  • PT 0.00
  • BIAF 0.01
  • Stochastic Oscillator
  • PT 57.14
  • BIAF 30.51

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

Share on Social Networks: